There are many types of tumor drugs on the market, but there are few indications, and the effect is not obvious or large. Studying a broad-spectrum, efficient and non-toxic new drug is the focus of many drug research teams.
After 7 years of research, a new anti-cancer ingredient was extracted, isolated and purified from a specially domesticated selenium-rich oyster mushroom, and named se-pop-3 and se-pop-21. Through a large number of experimental studies, Professor Zhong's team found that the special ingredients of SE-POP have a strong killing effect on eight types of cancer cells, including lung cancer, liver cancer, colorectal cancer, gastric cancer, prostate cancer, breast cancer, cervical cancer, and ovarian cancer, which can not only specifically kill cancer cells, but also prevent the metastasis and spread of cancer cells. It does not damage normal cells, but also repairs damaged cells.
The biggest difference between SEPOP and other anti-cancer ingredients is its non-toxicity and broad-spectrum properties. In addition to the specific apoptotic cancer cells and the role of preventing the metastasis and spread of cancer cells, a large number of studies by Professor Zhong's team have shown that the most amazing thing about SEPOP is that it can promote the secretion of T cells. Cancer patients have weakened immunity and their immune system may be in a state of collapse. The most effective fight against cancer cells is actually the body's own immune defense mechanism. Activating and regulating the immune system of cancer patients can not only improve the mental state of cancer patients, but also increase the absorption efficiency of the human body.
At present, a total of 4 papers in this study have been published in world-class SCI journals, and the influencing molecule has a score of 5, which has been widely recognized by world-class scholars. And this research result has been authorized by the state for 8 anti-cancer drug patents and 1 patent for regulating immunity. Clinical trials have been widely opened in many regions of Hunan, and those who need to contact Professor Zhong's team can participate in clinical trials.